 |
 |
 |
 |
 |
 |
|
|
At Avila Therapeutics, we design and develop targeted covalent drugs to achieve best-in-class outcomes that cannot be achieved through traditional medicinal chemistry. By selectively forming strong and durable covalent bonds that silence challenging disease targets, we can significantly impact disease. Avila is leading the way to broadly and systematically develop targeted covalent drugs that can treat diseases in new and better ways. Using our proprietary Avilomics™ platform, we are rapidly developing a pipeline of these innovative small molecule therapies for a number of diseases, including cancers, autoimmune diseases, and hepatitis C. |
